ACTRN12621000716864已完成4 期
A randomised controlled trial of testosterone treatment on gender dysphoria, depression, suicidality and quality of life in transgender men
niversity of Melbourne0 个研究点目标入组 64 人开始时间: 2021年6月8日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Transgender men newly commencing testosterone therapy.
排除标准
- •Contraindication to testosterone
- •Elevated haematocrit at baseline
- •Previous testosterone treatment
- •History of major psychiatric disease or psychological condition that may limit understanding and compliance with study requirements
- •Medications for antiplatelet or anticoagulant therapy
研究者
相似试验
招募中
3 期
Testosterone therapy for the treatment of nonalcoholic fatty liver diseaseNonalcoholic fatty liver diseaseACTRN12619000701123Austin Health120
招募中
不适用
Clinical trial of testosterone replacement therapy for the male hypogonadotropic hypogonadism with pituitary or hypothalamic tumor.JPRN-UMIN000033962Department of Metabolic Medicine. Osaka University Graduate School of Medicine30
已完成
3 期
A randomised placebo-controlled trial of testosterone undecanoate in obese men as adjuvant therapy for a weight loss programObstructive Sleep Apnea (OSA)Respiratory - Sleep apnoeaDiet and Nutrition - ObesityACTRN12606000404527The Woolcock Institute of Medical Research60
已完成
不适用
The PROOF trial: PROtecting Ovaries and Fertility during chemotherapyISRCTN96797814Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute30
已完成
不适用
Examination of the usefulness of testosterone cream for Late Onset Hypogonadism syndromeOH SyndromeJPRN-UMIN000029540Chibanisi-General Hospital200